Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 3/20 | 0.44 |
| ▸ | MALT1 | Q9UDY8 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | PSD | A5PKW4 | 1/20 | 0.33 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28836651 | 0.94 | DHODH (0.45) | DHODHMALT1KMT2AMEN1NTRK1 | |
| SCHEMBL30473348 | 0.94 | DHODH (0.45) | DHODHMALT1KMT2AMEN1NTRK1 | |
| SCHEMBL902720 | 0.93 | DHODH (0.46) | DHODHMALT1KMT2AMEN1TRPV1 | |
| SCHEMBL28867325 | 0.92 | DHODH (0.45) | DHODHMALT1KMT2AMEN1TRPV1 | |
| SCHEMBL17644462 | 0.91 | DHODH (0.43) | DHODHMALT1KMT2AMEN1NTRK1 | |
| SCHEMBL2396376 | 0.91 | DHODH (0.43) | DHODHMALT1KMT2AMEN1NTRK1 | |
| SCHEMBL15984455 | 0.91 | DHODH (0.44) | DHODHMALT1NTRK1TRPV1PSD | |
| SCHEMBL29377193 | 0.91 | DHODH (0.44) | DHODHMALT1NTRK1TRPV1PSD | |
| Chlorantraniliprole SCHEMBL29551 | 0.91 | DHODH (0.44) | DHODHMALT1NTRK1TRPV1PSD | |
| Chlorantraniliprole SCHEMBL29363261 | 0.91 | DHODH (0.44) | DHODHMALT1NTRK1TRPV1PSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8012499-B2 | Anthranilamides for controlling invertebrate pests | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-09-06 | — | — | US | claimed |
| US-20090269300-A1 | Anthranilamides for Controlling Invertebrate Pests | FINKELSTEIN BRUCE LAWRENCE | 2009-10-29 | — | — | US | claimed |
| EP-1924575-A1 | ANTHRANILAMIDES FOR CONTROLLING INVERTEBRATE PESTS | E.I.Du pont de nemours and company (US) | 2008-05-28 | — | — | EP | claimed |
| WO-2007024833-A1 | ANTHRANILAMIDES FOR CONTROLLING INVERTEBRATE PESTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-03-01 | — | — | WO | claimed |
| US-8012499-B2 | Anthranilamides for controlling invertebrate pests | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-09-06 | — | — | US | disclosed |
| US-20090269300-A1 | Anthranilamides for Controlling Invertebrate Pests | FINKELSTEIN BRUCE LAWRENCE | 2009-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090269300-A1 | Anthranilamides for Controlling Invertebrate Pests | CYB5R3, CBR3, ANTXR2 | DHODH 2158/4885MALT1 2601/4885KMT2A 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.